supplementary_information_revision.docx (1.5 MB)
Download fileCost-effectiveness analysis of nivolumab plus cabozantinib versus sunitinib as first-line therapy in advanced RCC.
figure
posted on 2022-06-27, 07:34 authored by Jianxin Pang, Peihao Wu, Yanqing Jiang, Junyan Wu, Kaifeng Qiu, Ruizhe LiuFigure S1. Kaplan–Meier curves and modelled curves.
